European Commission secures EU access to Remdesivir for treatment of COVID-19

coronavirus 2021

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will be made available to Member States and the UK, with the coordination and support of the Commission.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “In recent weeks, the Commission has been working tirelessly with Gilead to reach an agreement to ensure that stocks of the first treatment authorised against COVID-19 are delivered to the EU. A contract has been signed yesterday, less than a month after the authorisation of Remdesivir, which will allow the delivery of treatments from early August for thousands of patients. The Commission is leaving no stone unturned in its efforts to secure access to safe and efficient treatments, and is supporting the development of vaccines against coronavirus. Yesterday’s agreement is another important step forward in our fight to overcome this disease”.

The Commission’s Emergency Support Instrument will finance the contract, worth a total of €63 million. This will ensure the treatment of approximately 30,000 patients presenting severe COVID-19 symptoms. This will help to cover the current needs over the next few months, while ensuring a fair distribution at EU level, based on an allocation key, taking into account the advice from the European Centre for Disease Prevention and Control.

The Commission is now also preparing a joint procurement for further supplies of the medicine, expected to cover additional needs and supplies as from October onwards.

Background

On 3 July, Remdesivir became the first treatment to be authorised for a conditional marketing authorisation. This authorisation facilitates early access to medicines in public health emergency situations, such as the current pandemic.

Remdesivir is a treatment against COVID-19 for adults and adolescents as from age 12 with pneumonia who require supplemental oxygen. The application for the marketing authorisation was submitted to the European Medicines Agency (EMA) on 8 June. EMA’s recommendation was endorsed by the Member States through the Standing Committee on Medicinal Products for Human Use.

While authorised in the EU, the medicine continues to be monitored to ensure safety. Gilead has also been requested to submit the final reports of the Remdesivir studies to the EMA by December 2020 as part of the conditions to be fulfilled to move from a conditional marketing authorisation to a full marketing authorisation. Further data on the effectiveness and safety of the medicine is expected to be submitted by August 2020 in order to finalise this process.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

EU to finance new investment projects with extra borrowing; French and Italian deficits to be tolerated

‘Stealing’ food from hungry Yemenis ‘must stop immediately’, says UN agency

Germany may have a stable and more cooperative government

‘Green economy’ pioneer Pavan Sukhdev wins 2020 Tyler Prize for Environmental Achievement

European Commission: the LED lights of your Audi A6 shall save our planet

Africa will develop with oil and gas – whether the West likes it or not

Madagascar villagers learn dangers of outdoor defecation

Nagorno Karabakh: EU allocates additional €3 million in emergency aid for civilians affected by the hostilities

Does upgrading our minds mean losing the spark of genius?

This is how much the US-China trade war could cost the world, according to new research

“Beating pollution for our planet”, a Sting Exclusive by Mr Erik Solheim, the Executive Director of the United Nations Environment

FROM THE FIELD: South Sudan’s green shoots, highlight environmental recovery from war

OECD economic scenarios to 2060 illustrate the long-run benefits of structural reforms

3 hard-won lessons from a decade of negative cleantech returns

JADE visits Lithuanian Junior Initiatives

Online platforms: improving transparency and fairness for EU businesses

Young people demand a transparent job market: new campaign launches on international interns day

What cybersecurity professionals can learn from triathletes

European Youth Forum welcomes strong stance on human rights in State of the Union

Soil pollution ‘jeopardizing’ life on Earth, UN agency warns on World Day

Statement by the European Commission following the extraordinary meeting of the EU-UK Joint Committee

At UN, Yemen Foreign Minister demands end to ‘Iranian-Houthi coup d’etat’

Most ‘precious’ and ‘scarce’ resource of our time is dialogue, UN chief tells Doha policy forum

3 reasons why AI won’t replace human translators… yet

The British “nonsense”, the relaxed Commissioner and the TTIP “chiaroscuro” at this week’s Council

Mental Health in times of a pandemic: what can each individual do to lessen the burden?

UN forum spotlights cities, where struggle for sustainability ‘will be won or lost’

Malaria could be gone by the middle of the century. Here’s how

As inequality grows, the UN fights for a fairer world

ECB’s trillion has to be printed and distributed fast before Armageddon comes

EU-China: Commission and China hold first High-level Digital Dialogue

Youth policy in Europe not delivering for young people

No great discovery was made without a bold guess – Isaac Newton

What my transgender child can teach us about the workforce of the future

EU to spend €6 billion on youth employment and training futile schemes

EU reconfirms support for Afghanistan at 2020 Geneva Conference

European Banking Union: Like the issue of a Eurobond?

Eurozone dignitaries play with people’s life savings

Why cybersecurity should be standard due diligence for investors

What we need is more (and better) multilateralism, not less

‘Be the change’ we desperately need, UN deputy chief urges global youth

The EU pretends not knowing what happens in the Western Balkans

COVID-19 underlines the importance of fintech in emerging markets

Deep chasm still divides Athens and Brussels; can Eurozone use the nuclear arm of liquidity against Greece?

Mental health and suicide prevention – what can be done to increase access to mental health services in my local area?

Pandemic and mental health: what to do in this context?

Renovation Wave: doubling the renovation rate to cut emissions, boost recovery and reduce energy poverty

TTIP update: postponed vote and INTA meeting shuffle cards again

Economic uncertainty, geopolitical tensions stall growth in Latin America and Caribbean region, UN says

More progress needed on reducing and redesigning agricultural support policies

The road ahead to building a more sustainable world

After the Italian ‘no’ and the Brexit, Germans must decide which Europe they want

Northern Ireland: Parliament wants to secure post-Brexit regional funding

Commission welcomes agreement on the modernisation of EU export controls

Celebrating Gaston Ramon – the vet who discovered vaccinology’s secret weapon

Security Council should ‘nurture’ Colombian consensus against return to violence, top UN official urges

How to make primary healthcare a favourable career choice for medical students: strategies and reflections

Media and entertainment in flux: it’s time for the close-up

Is 2019 the beginning of the end for coal in Europe?

Greferendum: the biggest political gaffe in western modern history to tear Europe apart? #Grexit #Graccident

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s